Milbank Advises EQT on Acquisition of Anticimex

Anticimex is a leading global pest control specialist and employs around 7,400 people serving more than 3 million customers in 20 markets worldwide. Anticimex will become the first investment of EQT’s new strategy with longer-term investments and impact at its core.

The transaction with an enterprise value of approx. € 6 billion is made together with several long-term investors, including Melker Schörling AB, GIC, AMF and Interogo.

The transaction is expected to close in Q4 2021.

The Milbank team was led by Steffen Oppenländer (Corporate/M&A, Munich) and included partners Thomas Kleinheisterkamp (Tax, Munich); Alexander Rinne (Regulatory, Munich); and Joel Harrison (Technology, London) as well as associates Laura Treublein and

Markus von Lutterotti (both Corporate/M&A, Munich); Roy Jackson (Corporate/M&A, Los Angeles); Chris Puttock (Technology, London); Javier Ramos (Litigation, Washington); Stephanie Kam (Global Projects, Singapore); Melchior Raiser and Anna Merkl (both Banking & Leveraged Finance, Munich); as well as Nils Bremer (Regulatory, Munich).